BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28358240)

  • 1. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Pulli B; Wojtkiewicz G; Iwamoto Y; Ali M; Zeller MW; Bure L; Wang C; Choi Y; Masia R; Guimaraes AR; Corey KE; Chen JW
    Radiology; 2017 Aug; 284(2):390-400. PubMed ID: 28358240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice.
    Akai H; Kiryu S; Ohta Y; Yasaka K; Nakano Y; Inoue Y; Ohtomo K
    Magn Reson Imaging; 2017 May; 38():123-128. PubMed ID: 28062263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.
    Su HS; Nahrendorf M; Panizzi P; Breckwoldt MO; Rodriguez E; Iwamoto Y; Aikawa E; Weissleder R; Chen JW
    Radiology; 2012 Jan; 262(1):181-90. PubMed ID: 22084204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
    Yamada T; Kashiwagi Y; Rokugawa T; Kato H; Konishi H; Hamada T; Nagai R; Masago Y; Itoh M; Suganami T; Ogawa Y; Abe K
    Magn Reson Imaging; 2019 Apr; 57():210-217. PubMed ID: 30465867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
    Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
    Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
    Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
    Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
    Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G
    Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.
    Okada M; Katsube T; Kumano S; Kagawa Y; Araki T; Tsuda N; Okuaki T; Imaoka I; Tanigawa N; Ishii K; Murakami T
    Acta Radiol; 2011 Jul; 52(6):658-64. PubMed ID: 21498305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis.
    Lake AD; Hardwick RN; Leamon CP; Low PS; Cherrington NJ
    Toxicol Appl Pharmacol; 2019 Apr; 368():49-54. PubMed ID: 30794826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits.
    Xie Y; Zhang H; Jin C; Wang X; Wang X; Chen J; Xu Y
    Magn Reson Imaging; 2018 May; 48():34-41. PubMed ID: 29278765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
    Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
    Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.
    Wu Z; Matsui O; Kitao A; Kozaka K; Koda W; Kobayashi S; Ryu Y; Minami T; Sanada J; Gabata T
    J Magn Reson Imaging; 2013 May; 37(5):1137-43. PubMed ID: 23172731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Zhou IY; Clavijo Jordan V; Rotile NJ; Akam E; Krishnan S; Arora G; Krishnan H; Slattery H; Warner N; Mercaldo N; Farrar CT; Wellen J; Martinez R; Schlerman F; Tanabe KK; Fuchs BC; Caravan P
    Radiology; 2020 Jul; 296(1):67-75. PubMed ID: 32343209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.
    Pulli B; Bure L; Wojtkiewicz GR; Iwamoto Y; Ali M; Li D; Schob S; Hsieh KL; Jacobs AH; Chen JW
    Radiology; 2015 May; 275(2):480-9. PubMed ID: 25494298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.
    DeLeo MJ; Gounis MJ; Hong B; Ford JC; Wakhloo AK; Bogdanov AA
    Radiology; 2009 Sep; 252(3):696-703. PubMed ID: 19546428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase-Sensitive
    Liu J; Yu X; Ting HJ; Wang X; Xu S; Wang Y; Zhang S; Wang JW; Liu B
    ACS Nano; 2023 Feb; 17(4):3324-3333. PubMed ID: 36773320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis.
    Waghorn PA; Ferreira DS; Erstad DJ; Rotile NJ; Masia R; Jones CM; Tu C; Sojoodi M; Chen YI; Schlerman F; Wellen J; Martinez RVP; Tanabe KK; Fuchs BC; Caravan P
    Sci Rep; 2021 Mar; 11(1):6105. PubMed ID: 33731798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.